Almirall SA - Company Profile
Powered by 
All the sales intelligence you need on Almirall SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Almirall SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Almirall SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Almirall SA patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230374158A1 | Application | Bispecific molecules and methods of treatment using the same | C07K16/468; C07K2317/24; C07K2317/31 | November 23, 2023 |
| FI2265257T4 | Grant | Inhalation composition containing aclidinium for treatment of chronic obstructive pulmonary disease | A61P11/08; A61K9/0075; A61K9/14; A61K9/145; A61K2300/00; A61K2121/00; A61K31/167; A61K31/46; A61P11/06; A61K45/06; A61P11/00; A61K31/439 | November 22, 2023 |
| EP2265257B2 | Grant | Inhalationszusammensetzung enthaltend aclidinium zur behandlung von chronisch-obstruktiver lungenerkrankung | A61P11/00; A61P11/08; A61K31/46; A61P11/06; A61K31/167; A61K31/439; A61K9/145; A61K45/06; A61K2121/00; A61K9/0075; A61K2300/00; A61K9/14 | October 25, 2023 |
| EP3654988B1 | Grant | Sarecyclin zur behandlung von nicht-entzündlichen akneläsionen | A61K31/65; A61K9/0053; A61P17/10 | September 06, 2023 |
| EP4229085A1 | Application | Bispezifische moleküle und behandlungsverfahren damit | C07K16/244; C07K16/2866; C07K16/2875; C07K16/2878; C07K16/468; C07K2317/24; C07K2317/31 | August 23, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer